Clinical Trial

aiTBS for NSSI and Suicide in Adolescent Depression

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 16, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
Repetitive transcranial magnetic stimulation (rTMS) has been successfully used to help patients with treatment resistant depression. However, its role in alleviating self injuries with and without suicidal ideation remained uncertain. This trial will compare the effectiveness of active accelerated intermittent theta burst stimulation (aiTBS) rTMS to a placebo control on non-suicidal self injury (NSSI) and suicidal attempts in patients with major depressive disorder.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-01-06; most recent amendment 2024-08-15.
Status change: Not Yet Recruiting → Recruiting 2024-01-18
Trial Details
NCT Number NCT06210100
Lead Sponsor Central South University
Conditions Non Suicidal Self Injury, Suicidal Ideation, Suicide and Self-harm
Enrollment 60 participants
Start Date 2024-01-18
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-02-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-16